Albemarle Corporation Further Revised its 2022 Outlook 
<p><a href='https://financialmodelingprep.com/financial-summary/ALB'>Albemarle Corporation (NYSE:ALB) </a>announced further revision for its full 2022-year guidance, which reflects primarily the additional implementation of index-referenced variable-price contracts for battery grade lithium sales. The company now expects Lithium pricing to be up 140% year-over-year, compared to the prior estimate of up 100% year-over-year.</p>
<p>Net sales are now expected to range from $5.8 billion to $6.2 billion, compared to the previous outlook range of $5.2 billion to $5.6 billion and the Street estimate of $5.44 billion. Adjusted EBITDA is now expected in the range of $2.2 - $2.5 billion, compared to the previous outlook of $1.7 - $2.0 billion. </p>
<p>Adjusted diluted EPS is expected in the range of $12.30 - $15.00, compared to the previous outlook of $9.25 - $12.25 and the Street estimate of $10.88.</p>

NYSE:ALB